Liposome-mediated suicide gene therapy in humans

Methods in Enzymology

Volumn 391, Issue SPEC. ISS., 2005, Pages 200-208

  Reszka, Regina C ^a   Jacobs, Andreas ^a   Voges, Jürgen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; LIPOSOME; THYMIDINE KINASE;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG METABOLISM; DRUG TOLERABILITY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; MOLECULAR IMAGING; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIDE EFFECT; SUICIDE GENE THERAPY; TUMOR VOLUME;

HUMAN HERPESVIRUS 1;

EID: 13844275414     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)91012-4     Document Type: Article

References (40)

1. Anwer K., Sullivan S.M. Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther. 7:2000;1156-1164
2. Asklund T., Almqvist P.M. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp. Cell Res. 284:2003;185-195
3. Becker K., Whitley C.B. Real-time quantitative polymerase chain reaction to assess gene transfer. Hum. Gene Therapy. 10:1999;2559-2566
4. Boviatsis E.J., Chiocca E.A. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54:1994;5745-5751
5. Check E. Safety panel backs principle of gene-therapy trials. Nature. 420:2002;595
6. Chen S.H., Woo S.L. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;3054-3057
7. Culver K.W., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552
8. Ezzedine Z.D., Breakefield X.O. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3:1991;608-614
9. Felgner J.H., Felgner P.L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:1994;2550-2561
10. Felgner P.L., Cheng S.H. Improved cationic lipid formulations for in vivo gene therapy. Ann. N.Y. Acad. Sci. 772:1995;126-139
11. Fillat C., Sangro B. Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/ganciclovir system: Fifteen years of application. Curr. Gene Ther. 3:2003;13-26
12. Gao X., Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2:1995;710-722
13. Jacobs A., Heiss W.D. Quantitative kinetics of [124I]FIAU in cat and man. J. Nucl. Med. 42:2001a;467-475
14. Jacobs A., Heiss W.D. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 358:2001b;727-729
15. Kawai S., Saisho H. Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay. J. Med. Virol. 58:1999;121-126
16. Klatzmann D., Philippon J. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum. Gene Ther. 9:1998;2595-2604
17. Lehrmann S. Nature. 401:1999;517
18. Marshall E. Gene therapy's growing pains. Science. 269:1995;1052-1055
19. Matthews T., Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10:1988;S490-494
20. Nabel G.J., Cho K. Immunotherapy for cancer by direct gene transfer into tumors. Hum. Gene Ther. 5:1994;57
21. Ogris M., Wagner E. Tumor-targeted gene transfer with DNA polyplexes. Somat. Cell Mol. Genet. 27:2002;85-95
22. O'Malley B.W. Suicide gene therapy. Templeton N. "Gene Therapy for Cancer: Therapeutic Mechanisms and Strategies" 2000;353-370 Marcel Dekker, New York
23. Preston-Martin S. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Berger M.S., Wilson C.B. "The Gliomas" 1999;2-6 W. B. Saunders Company, Philadelphia, PA
24. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11:2000;2389-2401
25. Ram Z., Oldfield E.H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53:1993;83-88
26. Ram Z., Oldfield E.H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3:1997;1354-1361
27. Reszka R., Walther W. Liposome mediated transfer of marker and cytokine genes into rat and human glioblastoma cells in vitro and in vivo. J. Liposome Res. 5:1995;149-167
28. Schätzlein A.G. Non-viral vectors in cancer gene therapy: Principles and progress. Anti-Cancer Drugs. 12:2001;275-304
29. Shand N., Barbier N. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum. Gene Ther. 10:1999;2325-2335
30. Takeshima H., Van Meir E.G. Application of advances in molecular biology to the treatment of brain tumors. Curr. Oncol. Rep. 2:2000;425-433
31. Tatter S.B., Harsh G.H. Neurosurgical management of brain tumors. Chiocca E.A., Breakfield X.O. "Gene Therapy for Neurological Disorders" 1998;161-170 Humana Press, Totowa, NJ
32. Tjuvajev J.G., Blasberg R.G. Imaging the expression of transfected genes in vivo. Cancer Res. 55:1995;6126-6132
33. Tjuvajev J.G., Blasberg R.G. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res. 56:1996;4087-4095
34. Tjuvajev J.G., Blasberg R. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:1998;4333-4341
35. Twombly R. For gene therapy, now-quantified risks are deemed troubling. J. Natl. Cancer Inst. 95:2003;1032-1033
36. van der Eb M.M., Hoeben R.C. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 5:1998;451-458
37. Voges J., Kapp J.F. Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme. Hum. Gene Ther. 13:2002;675-685
38. Voges J., Jacobs A. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann. Neurol. 55:2003;479-487
39. Von Eckardstein, Reszka R. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol. Histopathol. 16:2001;735-744
40. Zhu J., Reszka R. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Ther. 3:1996;472-476